Skip to main content
. 2022 Jun 13;6:100065. doi: 10.1016/j.ibmed.2022.100065

Table 3.

Summary of the baseline characteristics of the patient cohort in the training sets and test sets and the prevalence of the predicted complications. Note that n represents the total number of patients while % is the proportion of patients within the respective dataset.

Training set A Test set A Training set B Test set B
Patient Cohort
Encounters, n 1829 587 711 225
Age, mean (IQR) 41.7 (17.0) 45.5 (18.0) 39.3 (17.0) 42.7 (20.0)
Male, n (%) 1582 (86.5) 522 (88.9) 622 (87.5) 191 (84.8)
Arab, n (%) 295 (16.1) 89 (15.2) 120 (16.9) 43 (19.1)
Non-Arab, n (%) 1534 (83.9) 498 (84.8) 591 (83.1) 182 (80.9)
Mortality, n (%)
36 (2.0)
22 (3.7)
9 (1.3)
3 (1.3)
Complications
SBI, n (%) 92 (5.0) 45 (7.7) 23 (3.2) 17 (7.6)
Developed within 24 h from admission, n (%) 1 (0.1) 3 (0.5) 1 (0.1) 1 (0.4)
Developed after 24 h from admission, n (%)
91 (5.0)
42 (7.2)
22 (3.1)
16 (7.1)
AKI, n (%) 126 (6.9) 52 (8.9) 32 (4.5) 16 (7.1)
Developed within 24 h from admission, n (%) 28 (1.5) 9 (1.5) 14 (2.0) 3 (1.3)
Developed after 24 h from admission, n (%)
98 (5.4)
43 (7.3)
18 (2.5)
13 (5.8)
ARDS, n (%) 117 (6.4) 57 (9.7) 45 (6.3) 24 (10.7)
Developed within 24 h from admission, n (%) 61 (3.3) 26 (4.4) 23 (3.2) 13 (5.8)
Developed after 24 h from admission, n (%) 56 (3.1) 31 (5.3) 22 (3.1) 11 (4.9)